NI-0101, a Therapeutic TLR4 Monoclonal Antibody for Rheumatoid Arthritis
Auteurs principaux: | Elson, G, Page, T, Buatois, V, Daubeuf, B, Chatel, L, Cons, L, Lippens, C, Salgado-Pires, S, Ferlin, W, Kosco-Vilbois, M, Midwood, K, Shang, L |
---|---|
Format: | Conference item |
Publié: |
2011
|
Documents similaires
-
Therapeutic Effects of Treatment with Anti-TLR2 and Anti-TLR4 Monoclonal Antibodies in Polymicrobial Sepsis.
par: Cristiano Xavier Lima, et autres
Publié: (2015-01-01) -
CD47xCD19 bispecific antibody triggers recruitment and activation of innate immune effector cells in a B-cell lymphoma xenograft model
par: Xavier Chauchet, et autres
Publié: (2022-05-01) -
Prospects of pharmacotherapy for rheumatoid arthritis: Monoclonal antibodies
par: Evgeny Lvovich Nasonov, et autres
Publié: (2012-06-01) - ESTATES & GAZETTE NO.0101 - 0103 2001
-
Raised circulating tenascin-C in rheumatoid arthritis.
par: Page, T, et autres
Publié: (2012)